Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pleural Effusion, Malignant 4Pleural Effusion 2Wound Infection 1Urinary Tract Infections 1Stomatitis 1Skin Neoplasms 1Sepsis 1Prostatic Neoplasms 1Pneumothorax 1Head and Neck Neoplasms 1Fever 1Esophageal Neoplasms 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Povidone-Iodine × Clear all
NCT02479347 2021-09-09

Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 4 Completed
2,158 enrolled
Breast

Breast Neoplasms, Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡